Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Maxon

Polyglyconate (5) is made by the bulk copolymerisation of a mixture of 67% glycoHde and 33% trimethylene carbonate. The suture is distributed under the trade names Maxon and Maxon CV. It is claimed to retain approximately 50% of its strength four weeks after implantation, 25% at six weeks, and to be essentially completely absorbed ia six months. [Pg.268]

Other scale-up factors are shear, mixing time, Reynolds number, momentum, and the mixing provided by rising bubbles. Shear is maximum at the tip of the impeller and may be estimated from Eq. (24-5), where the subscripts s and I stand for small and large and Di is impeller diameter [R. Steel and W. D. Maxon, Biotechnm. Bioengn, 4, 231 (1962)]. [Pg.2140]

Unfortunately, relatively little information has been made available for industrial gas-liquid contactors. Further data from industry could permit significant tests of the reliability of the present correlations and their applicability to scale-up. Steel and Maxon (SI 1) reported on the power requirements during novobiacin fermentation in 20- and 250-liter pilot-plant vessels and in 12,000- and 24,000-gal vessels. The comparative data are difficult to evaluate because of changes that occurred in viscosity and gas retention during the course of the fermentation. In addition, geometric similarity did not prevail... [Pg.323]

Weininger J, Ketring AR, Deutsch E, Maxon HR, Goeckeler WR (1983) J Nucl Med 24 P125... [Pg.290]

Deutsch E, Libson K, Vanderheyden J-L, Ketring AR, Maxon HR (1986) Nucl Med Biol 13 465... [Pg.290]

Maxon III HR, Schroder LE, Thomas SR, Hertzberg VS, Deutsch EA, Scher HI, Samaratunga RC, Libson KF, Williams CC, Moulton JS, Schneider HJ (1990) Radiology 176 155... [Pg.290]

Maximum working-solution capacity, 14 46 Maximum work obtainable, for a change of state involving mixtures, 24 690-692 Maxixe beryl, color, 7 337 Maxon sutures, 24 222 Maxwell-Boltzmann distribution, silicon-based semiconductors and, 22 235, 236, 238... [Pg.556]

Askenazi M, Driggers EM, Holtzman DA, Norman TC, Iverson S, Zimmer DP, Boers ME, Blomquist P, Martinez EJ, Monreal AW, Feibelman TP, Mayorga ME, Maxon ME, Sykes K, Tobin JV, Cordero E, Salama SR, Trueheart J, Royer JC, Madden KT. (2003) Integrating transcriptional and metabolite profiles to direct the engineering of lovastatin-producing fungal strains. Nature Biotechnol 21 150-156. [Pg.627]

Thomas SR, Maxon HR, Fritz KM, Kereiakes JG, Connell WD. A comparison of methods for assessing patient body burden following 131I therapy for thyroid cancer. Radiology 1980 137(3) 839 12. [Pg.327]

Maxon HR, Thomas SR, Chen IW. The role of nuclear medicine in the treatment of hyperthyroidism and well-differentiated thyroid adenocarcinoma. Clin Nucl Med 1981 6( 1 OS) P87-98. [Pg.327]

Haugen BR, Pacini F, Reiners C, Schlumberger M, Ladenson PW, Sherman SI, Cooper DS, Graham KE, Braverman LE, Skarulis MC, Davies TF, DeGroot LJ, Mazzaferri EL, Daniels GH, Ross DS, Luster M, Samuels MH, Becker DV, Maxon HR 3rd, Cavalieri RR, Spencer CA, McEllin K, Weintraub BD, Ridgway EC. A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer. J Clin Endocrinol Metab 1999 84(11) 3877—85. [Pg.355]

See other pages where Maxon is mentioned: [Pg.597]    [Pg.481]    [Pg.265]    [Pg.324]    [Pg.393]    [Pg.394]    [Pg.403]    [Pg.78]    [Pg.108]    [Pg.221]    [Pg.330]    [Pg.290]    [Pg.290]    [Pg.1122]    [Pg.141]    [Pg.141]    [Pg.141]    [Pg.141]    [Pg.142]    [Pg.142]    [Pg.142]    [Pg.142]    [Pg.142]    [Pg.122]    [Pg.382]    [Pg.402]    [Pg.265]    [Pg.597]    [Pg.256]    [Pg.428]    [Pg.447]    [Pg.727]    [Pg.396]    [Pg.433]    [Pg.101]    [Pg.33]    [Pg.33]    [Pg.88]   
See also in sourсe #XX -- [ Pg.46 , Pg.73 ]

See also in sourсe #XX -- [ Pg.235 , Pg.238 , Pg.278 ]



SEARCH



Maxon monofilament

Poly Maxon

© 2024 chempedia.info